¼¼°èÀÇ ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2033³â)
Peripheral Stent Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Persistence Market Research´Â ÃÖ±Ù ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ¼¼°è ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ º¸°í¼¸¦ ¹ßÇ¥Çß½À´Ï´Ù. º» º¸°í¼¿¡¼´Â ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, µ¿Çâ, ±âȸ, ÃËÁø¿äÀÎ, °úÁ¦ µîÀÇ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÈ÷ Æò°¡ÇÏ¿© ½ÃÀå ±¸Á¶¿¡ ´ëÇÑ »ó¼¼ÇÑ ÅëÂûÀ» Á¦°øÇÕ´Ï´Ù.
ÁÖ¿ä ÀλçÀÌÆ®
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀå ±Ô¸ð(2024E) : 41¾ï ´Þ·¯
¿¹Ãø ½ÃÀå °¡Ä¡(2033F) : 75¾ï ´Þ·¯
¼¼°è ½ÃÀå ¼ºÀå·ü(CAGR 2024³âºÎÅÍ 2033³â±îÁö) : 6.9%
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀå - º¸°í ¹üÀ§:
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ®´Â ´Ù¸®¿Í ÆÈ°ú °°Àº ½ÉÀå ÀÌ¿ÜÀÇ ¸»ÃÊ Ç÷°ü°è¿¡¼ ÇùÂøµÇ°Å³ª ¸·Èù µ¿¸ÆÀ» ¿©´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ½ºÅÙÆ®´Â ÀûÀýÇÑ Ç÷·ù¸¦ ȸº¹½ÃŰ°í »çÁöÀÇ ÇãÇ÷°ú °°Àº ½É°¢ÇÑ ÇÕº´ÁõÀ» ¿¹¹æÇÕ´Ï´Ù. ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀº ¸»ÃÊ µ¿¸Æ Áúȯ(PAD)ÀÇ À¯º´·ü Áõ°¡, ½ºÅÙÆ® ±â¼úÀÇ Áøº¸, ³·Àº ħ½À ÀýÂ÷¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼´Â º£¾î ¸ÞÅ» ½ºÅÙÆ®, ¾à¹° ¿ëÃâ ½ºÅÙÆ®, »ýü Èí¼ö¼º ½ºÅÙÆ® µî ´Ù¾çÇÑ À¯ÇüÀÇ ½ºÅÙÆ®¿Í ´Ù¾çÇÑ È¯ÀÚÃþ¿¡¼ÀÇ ¿ëµµ¿¡ ´ëÇÑ ÅëÂû·ÂÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:
¼¼°èÀÇ ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀº °í·ÉÈ, ´ç´¢º´, »ýȰ ½À°ü°ú °ü·ÃµÈ À§Çè ÀÎÀÚ·Î ÀÎÇÑ PAD ¹ß»ý·ü Áõ°¡ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀο¡ ÀÇÇØ ÃßÁøµÇ°í ÀÖ½À´Ï´Ù. ¾à¹° ¿ëÃ⼺ ½ºÅÙÆ®¿Í »ýü Èí¼ö¼º ½ºÄ³ÆúµåÀÇ °³¹ß µî ±â¼úÀÇ Áøº¸°¡ Ä¡·á ¼ºÀûÀ» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¸º¹ ½Ã°£ÀÌ Âª°í ÇÕº´Áõ ¹ß»ý·üÀÌ ³·Àº ħ½À ¼ö¼ú·ÎÀÇ ÀüȯÀÌ ½ºÅÙÆ® À̽ÄÀÇ Ã¤¿ëÀ» ´Ã¸®°í ÀÖ½À´Ï´Ù. Ç÷°üÀÇ °Ç° ÁõÁøÀ» ¸ñÀûÀ¸·Î ÇÑ Á¤ºÎÀÇ ´ëó³ª ÇコÄɾî Á¤Ã¥µµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:
À¯¸ÁÇÑ ¼ºÀå Àü¸ÁÀÌ ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀº ³ôÀº ºñ¿ë°ú »óȯ ¹®Á¦¿Í °ü·ÃµÈ ¹®Á¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ÃֽнºÅÙÆ®¿¡ »ç¿ëµÇ´Â °í±Þ ±â¼úÀº Á¾Á¾ ³ôÀº °¡°ÝÀ¸·Î À̾îÁö¹Ç·Î ƯÈ÷ ½ÅÈï ±¹°¡¿¡¼´Â ȯÀÚ¿Í °Ç° °ü¸® Á¦°ø¾÷ü¿¡°Ô À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀçÇùÂøÀ̳ª ½ºÅÙÆ® Ç÷ÀüÁõ µîÀÇ ÇÕº´ÁõÀÌ ÀÓ»ó»óÀÇ °úÁ¦°¡ µÇ¾î ½ÃÀåÀÇ ¼ºÀåÀ» Á¦ÇÑÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ½ÅÁ¦Ç° ½ÂÀÎÀ» µÞ¹ÞħÇÏ´Â Àå±âÀûÀÎ ÀÓ»ó µ¥ÀÌÅÍÀÇ Çʿ伺µµ ½ÃÀå ÁøÃâÀÚ¿¡°Ô ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù.
½ÃÀå ±âȸ:
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀº ÇöÀç ÁøÇà ÁßÀÎ ¿¬±¸ °³¹ß, Ç÷°ü Áúȯ¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í, ½ÅÈï±¹ ½ÃÀå¿¡¼ ÇコÄɾî ÀÎÇÁ¶óÀÇ È®´ë°¡ Å« ¼ºÀå ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. »ýü ÀûÇÕ¼º, À¯¿¬¼º ¹× ¾à¹° Àü´Þ ±â´ÉÀ» Çâ»ó½ÃŲ Â÷¼¼´ë ½ºÅÙÆ®ÀÇ °³¹ßÀº Ä¡·á ¼ºÀûÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´À» ÃßÁøÇÏ´Â ±â¾÷Àº Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ, ÀÇ·á Á¦°øÀÚ¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê ±¸Ãà, ȯÀÚ Á᫐ Á¦Ç° °³¹ß¿¡ ÁÖ·ÂÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °æÇâÀÇ ³ô¾ÆÁü°ú °íµµÀÇ È»ó ±â¼úÀÇ Ã¤¿ëµµ, ½ÃÀå ¼ºÀåÀÇ ±æÀ» ¿¬´Ù.
ÀÌ º¸°í¼¿¡¼ ´Ù·ç´Â ÁÖ¿ä Áú¹®
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
´Ù¾çÇÑ È¯ÀÚÃþ¿¡¼ ä¿ëÀ» ¼±µµÇÏ´Â ½ºÅÙÆ®ÀÇ À¯Çü°ú ±â¼úÀº?
±â¼úÀÇ Áøº¸´Â ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀå °æÀï ±¸µµ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?
¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ±â¾÷Àº ´©±¸ÀÌ¸ç ½ÃÀå °ü·Ã¼ºÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
¼¼°èÀÇ ¸»ÃÊ Ç÷°ü ½ºÅÙÆ® ÀÓÇöõÆ® ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ°ú Àü¸ÁÀº?
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå °³¿ä
½ÃÀå ¹üÀ§/ºÐ·ù
½ÃÀåÀÇ Á¤ÀÇ/¹üÀ§/Á¦ÇÑ
Æ÷ÇÔ°ú Á¦¿Ü
Á¦3Àå ÁÖ¿ä ½ÃÀå µ¿Çâ
½ÃÀå¿¡ ¿µÇâÀ» ÁÖ´Â ÁÖ¿ä µ¿Çâ
½ÃÀåÀÇ Çõ½Å/°³¹ß µ¿Çâ
Á¦4Àå Áß¿äÇÑ ¼º°ø ¿äÀÎ
Á¦Á¶¾÷üº° ÁÖ¿ä ÇÁ·Î¸ð¼Ç Àü·«
ÁÖ¿ä ±ÔÁ¦
PESTEL ºÐ¼®
Porter's Five Forces ºÐ¼®
Á¦Ç° ¹ß¸Å Ȱµ¿
Á¦Ç°ÀÇ Ã¤¿ë/»ç¿ë »óȲ ºÐ¼®
ȯºÒ
¹ë·ùüÀÎ ºÐ¼®
Á¦5Àå ½ÃÀå ¹è°æ
°Å½Ã°æÁ¦ ¿äÀÎ
¿¹Ãø ¿äÀÎ- °ü·Ã¼º°ú ¿µÇâ
½ÃÀå ¿ªÇÐ
Á¦6Àå COVID-19 À§±â ºÐ¼®
COVID-19¿Í ¿µÇ⠺м®
2024³â ½ÃÀå ½Ã³ª¸®¿À
Á¦7Àå ¼¼°è ½ÃÀå ±Ô¸ð('000 À¯´Ö) ºÐ¼®
½ÃÀå ±Ô¸ð('000 À¯´Ö) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð('000 À¯´Ö) ¿¹Ãø, 2024-2033³â
Á¦8Àå ¼¼°è ½ÃÀå - °¡°Ý ºÐ¼®
¼ÒÀ纰 Áö¿ªº° °¡°Ý ºÐ¼®
°¡°Ý ºÐ¼®
Á¦Á¶¾÷ü ·¹º§ÀÇ °¡°Ý ¼³Á¤
À¯Åë¾÷ü ·¹º§ÀÇ °¡°Ý ¼³Á¤
¼¼°è Æò±Õ °¡°Ý ºÐ¼® º¥Ä¡¸¶Å©
°¡°Ý ¼³Á¤ÀÇ ÀüÁ¦
Á¦9Àå ¼¼°è ½ÃÀå ¼ö¿ä(°¡Ä¡ ¶Ç´Â ±Ô¸ð, 10¾ï ´Þ·¯) ºÐ¼®
½ÃÀå ¸ÅÃâ(10¾ï ´Þ·¯)°ú ¼ö·®(õ´ë) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¼ö·®(õ´ë)ÀÇ ºÐ¼®°ú ¿¹Ãø, ½ÃÀå ºÐ·ùº°, 2024-2033³â
Àü³â´ëºñ ¼ºÀå µ¿Ç⠺м®
Àý´ë ¼öÀÍ ±âȸ
Á¦10Àå Á¦Ç°º° : ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¼ö·®(õ´ë) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¼ö·®(õ´ë)ÀÇ ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
º£¾î ¸ÞÅ» ½ºÅÙÆ®(BMS)
Ä¿¹ö ºÎÂø ½ºÅÙÆ®
¾àÁ¦ ¿ëÃâ ½ºÅÙÆ®(DES)
Á¦Ç°º° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦11Àå µ¿¸Æº°: ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
°æµ¿¸Æ ½ºÅÙÆ®
´ëÅ𠹫¸ µ¿¸Æ µ¿¸Æ ½ºÅÙÆ®
Àå°ñµ¿¸Æ ½ºÅÙÆ®
¹«¸ µ¿¸Æ Çϵ¿¸Æ ½ºÅÙÆ®
Artery¿¡ ÀÇÇÑ ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦12Àå ÃÖÁ¾ »ç¿ëÀÚº° ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯) ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
º´¿ø
¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)/¿Ü·¡ ȯÀÚ
ÃÖÁ¾ »ç¿ëÀÚº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦13Àå Áö¿ªº° ¼¼°è ½ÃÀå ºÐ¼®
¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¼ö·®(õ´ë) ºÐ¼®, 2019-2023³â
½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¼ö·®(õ´ë)ÀÇ ºÐ¼®°ú ¿¹Ãø, 2024-2033³â
ºÏ¹Ì
¶óƾ¾Æ¸Þ¸®Ä«
À¯·´
µ¿¾Æ½Ã¾Æ
³²¾Æ½Ã¾Æ
¿À¼¼¾Æ´Ï¾Æ
Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Áö¿ªº° ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
Á¦14Àå ºÏ¹Ì ½ÃÀå ºÐ¼®
Á¦15Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®
Á¦16Àå À¯·´ ½ÃÀå ºÐ¼®
Á¦17Àå µ¿¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦18Àå ³²¾Æ½Ã¾Æ ½ÃÀå ºÐ¼®
Á¦19Àå ¿À¼¼¾Æ´Ï¾Æ ½ÃÀå
Á¦20Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®
Á¦21Àå ½ÃÀå ±¸Á¶ ºÐ¼®
±â¾÷ Tierº° ½ÃÀå ºÐ¼®
ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
½ÃÀåÇöÀçºÐ¼®
Á¦22Àå °æÀï ºÐ¼®
°æÀï ´ë½Ãº¸µå
°æÀï º¥Ä¡¸¶Å·
°æÀïÀÇ »ó¼¼
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE &Co. KG
Boston Scientific Corporation
Cook Medical, Inc.
Cardinal Health, Inc.
iVascular SLU
Medtronic Plc.
Terumo Corporation
WL Gore &Associates Inc.
Á¦23Àå »ç¿ëµÈ ÀüÁ¦Á¶°Ç°ú ¾à¾î
Á¦24Àå Á¶»ç ¹æ¹ý
JHS
Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral stent implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
Peripheral Stent Implants Market Size (2024E): USD 4.1 Bn
Projected Market Value (2033F): USD 7.5 Bn
Global Market Growth Rate (CAGR 2024 to 2033): 6.9%
Peripheral Stent Implants Market - Report Scope:
Peripheral stent implants are vital medical devices used to open narrowed or blocked arteries in the peripheral vascular system, including the legs, arms, and other areas outside the heart. These stents help restore proper blood flow, preventing severe complications like limb ischemia. The market for peripheral stent implants is driven by the growing prevalence of peripheral artery disease (PAD), advancements in stent technology, and increasing demand for minimally invasive procedures. The report provides insights into various types of stents, such as bare-metal stents, drug-eluting stents, and bioresorbable stents, and their applications across different patient demographics.
Market Growth Drivers:
The global peripheral stent implants market is propelled by several key factors, including the rising incidence of PAD due to an aging population, diabetes, and lifestyle-related risk factors. Technological advancements, such as the development of drug-eluting stents and bioresorbable scaffolds, are enhancing treatment outcomes and driving market growth. Additionally, the shift towards minimally invasive procedures, which offer shorter recovery times and lower complication rates, is increasing the adoption of stent implants. Government initiatives and healthcare policies aimed at improving vascular health also contribute to market expansion.
Market Restraints:
Despite promising growth prospects, the peripheral stent implants market faces challenges related to high costs and reimbursement issues. The advanced technology used in modern stents often leads to higher prices, which can be a barrier for patients and healthcare providers, especially in emerging economies. Additionally, complications such as restenosis and stent thrombosis pose clinical challenges, potentially limiting market growth. Regulatory hurdles and the need for long-term clinical data to support new product approvals also present challenges for market players.
Market Opportunities:
The peripheral stent implants market presents significant growth opportunities driven by ongoing research and development, increasing awareness of vascular diseases, and expanding healthcare infrastructure in emerging markets. The development of next-generation stents with improved biocompatibility, flexibility, and drug-delivery capabilities offers potential for enhanced treatment outcomes. Market players can capitalize on these opportunities by investing in innovation, forming strategic partnerships with healthcare providers, and focusing on patient-centric product development. The growing trend towards personalized medicine and the adoption of advanced imaging technologies also create avenues for market growth.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the peripheral stent implants market globally?
Which types of stents and technologies are leading adoption across different patient demographics?
How are technological advancements influencing the competitive landscape of the peripheral stent implants market?
Who are the key players contributing to the peripheral stent implants market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global peripheral stent implants market?
Competitive Intelligence and Business Strategy:
Leading players in the global peripheral stent implants market, including Boston Scientific Corporation, Abbott Laboratories, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced stent solutions, including drug-eluting stents and bioresorbable scaffolds, catering to diverse clinical needs and regulatory standards. Collaborations with healthcare providers, research institutions, and regulatory bodies facilitate market access and promote technology adoption. Emphasis on clinical outcomes, patient safety, and cost-effectiveness drives market growth and reinforces the position of key players in the evolving vascular treatment landscape.
Key Companies Profiled:
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corporation
Cook Medical, Inc.
Cardinal Health, Inc.
iVascular SLU
Medtronic Plc.
Terumo Corporation
W. L. Gore & Associates Inc.
Key Segments Covered in Peripheral Stent Implants Industry Research
Product
Bare Metal Stents (BMS)
Covered Stents
Drug Eluting Stents (DES)
Artery
Carotid Artery Stents
Fem-Pop Artery Stents
Iliac Artery Stents
Infrapop Artery Stents
End User
Hospitals
Ambulatory Surgical Centers/Outpatient
Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)
Table of Contents
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends
4. Key Success Factors
4.1. Key Promotional Strategies, by Manufacturers
4.2. Key Regulations
4.3. PESTEL Analysis
4.4. Porter's Analysis
4.5. Product Launch Activities
4.6. Product Adoption/Usage Analysis
4.7. Reimbursement
4.8. Value Chain Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Global Peripheral Vascular Devices Outlook
5.2. Forecast Factors - Relevance & Impact
5.2.1. Top Companies Historical Growth
5.2.2. New Product Launches and Approvals
5.2.3. Global Peripheral Vascular Diseases
5.2.4. Research and Development Expenditure by Key Players
5.2.5. Historic and Current Revenue of Key Players
5.2.6. Rising Consumer Awareness of the Product
5.2.7. Rising Adoption of Device Technological Development
5.2.8. Strategic Developments by Key Players
5.2.9. Increasing Adoption of Peripheral Vascular Devices for Various Arteries
5.2.10. Strategic Collaborations among Players
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.1.1. By Product
6.1.2. By Artery
6.1.3. By End User
6.1.4. By Country
6.2. 2024 Market Scenario
7. Global Market Volume ('000 Units) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume ('000 Units) Analysis, 2019-2023
7.2. Current and Future Market Volume ('000 Units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market - Pricing Analysis
8.1. Regional Pricing Analysis By Material
8.2. Pricing Break-up
8.2.1. Manufacturer Level Pricing
8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Bn) and Volume ('000 Units) Analysis, 2019-2023
9.2. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis by Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Product, 2024-2033
10.3.1. Bare Metal Stents (BMS)
10.3.2. Covered Stents
10.3.3. Drug Eluting Stents (DES)
10.4. Market Attractiveness Analysis by Product
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Artery
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis by Artery, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Artery, 2024-2033
11.3.1. Carotid Artery Stents
11.3.2. Fem-Pop Artery Stents
11.3.3. Iliac Artery Stents
11.3.4. Infrapop Artery Stents
11.4. Market Attractiveness Analysis by Artery
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2033
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers/Outpatients
12.4. Market Attractiveness Analysis by End User
13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis, by Region, 2019-2023
13.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis Forecast by Region, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East & Africa
13.4. Market Attractiveness Analysis by Region
14. North America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Artery
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Artery
14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Artery
14.8.1.2.3. By End User
14.8.2. Canada Market
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Artery
14.8.2.2.3. By End User
15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Artery
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Artery
15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Artery
15.8.1.2.3. By End User
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Artery
15.8.2.2.3. By End User
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Artery
15.8.3.2.3. By End User
16. Europe Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Artery
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Artery
16.4.4. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Artery
16.8.1.2.3. By End User
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Artery
16.8.2.2.3. By End User
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Artery
16.8.3.2.3. By End User
16.8.4. U.K. Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Artery
16.8.4.2.3. By End User
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Artery
16.8.5.2.3. By End User
16.8.6. BENELUX Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Artery
16.8.6.2.3. By End User
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Artery
16.8.7.2.3. By End User
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Artery
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Artery
17.4.4. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Artery
17.8.1.2.3. By End User
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Artery
17.8.2.2.3. By End User
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Artery
17.8.3.2.3. By End User
18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Artery
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Artery
18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Artery
18.8.1.2.3. By End User
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Artery
18.8.2.2.3. By End User
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Artery
18.8.3.2.3. By End User
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Artery
18.8.4.2.3. By End User
19. Oceania Market 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Artery
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Artery
19.4.4. By End User
19.5. Market Trends
19.6. Key Market Participants - Intensity Mapping
19.7. Drivers and Restraints - Impact Analysis
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Artery
19.8.1.2.3. By End User
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Artery
19.8.2.2.3. By End User
20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Bn) and Volume ('000 Units) Analysis Trend Analysis by Market Taxonomy, 2019-2023
20.3. Current and Future Market Size (US$ Bn) and Volume ('000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkiye
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Artery
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Artery
20.4.4. By End User
20.5. Market Trends
20.6. Key Market Participants - Intensity Mapping
20.7. Drivers and Restraints - Impact Analysis
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Artery
20.8.1.2.3. By End User
20.8.1.3. Turkiye Market Analysis
20.8.1.4. Introduction
20.8.1.5. Market Analysis and Forecast by Market Taxonomy
20.8.1.5.1. By Product
20.8.1.5.2. By Artery
20.8.1.5.3. By End User
20.8.2. South Africa Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Artery
20.8.2.2.3. By End User
20.8.3. North Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Artery
20.8.3.2.3. By End User
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Abbott Laboratories
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Key Developments
22.3.1.7. Strategy Overview
22.3.1.7.1. Marketing Strategy
22.3.1.7.2. Product Strategy
22.3.1.7.3. Channel Strategy
22.3.2. B. Braun Melsungen AG
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Key Developments
22.3.2.7. Strategy Overview
22.3.2.7.1. Marketing Strategy
22.3.2.7.2. Product Strategy
22.3.2.7.3. Channel Strategy
22.3.3. Biotronik SE & Co. KG
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Key Developments
22.3.3.7. Strategy Overview
22.3.3.7.1. Marketing Strategy
22.3.3.7.2. Product Strategy
22.3.3.7.3. Channel Strategy
22.3.4. Boston Scientific Corporation
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Key Developments
22.3.4.7. Strategy Overview
22.3.4.7.1. Marketing Strategy
22.3.4.7.2. Product Strategy
22.3.4.7.3. Channel Strategy
22.3.5. Cook Medical, Inc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Key Developments
22.3.5.7. Strategy Overview
22.3.5.7.1. Marketing Strategy
22.3.5.7.2. Product Strategy
22.3.5.7.3. Channel Strategy
22.3.6. Cardinal Health, Inc.
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Key Developments
22.3.6.7. Strategy Overview
22.3.6.7.1. Marketing Strategy
22.3.6.7.2. Product Strategy
22.3.6.7.3. Channel Strategy
22.3.7. iVascular SLU
22.3.7.1. Overview
22.3.7.2. Product Portfolio
22.3.7.3. Sales Footprint
22.3.7.4. Key Financials
22.3.7.5. SWOT Analysis
22.3.7.6. Key Developments
22.3.7.7. Strategy Overview
22.3.7.7.1. Marketing Strategy
22.3.7.7.2. Product Strategy
22.3.7.7.3. Channel Strategy
22.3.8. Medtronic Plc.
22.3.8.1. Overview
22.3.8.2. Product Portfolio
22.3.8.3. Sales Footprint
22.3.8.4. Key Financials
22.3.8.5. SWOT Analysis
22.3.8.6. Key Developments
22.3.8.7. Strategy Overview
22.3.8.7.1. Marketing Strategy
22.3.8.7.2. Product Strategy
22.3.8.7.3. Channel Strategy
22.3.9. Terumo Corporation
22.3.9.1. Overview
22.3.9.2. Product Portfolio
22.3.9.3. Sales Footprint
22.3.9.4. Key Financials
22.3.9.5. SWOT Analysis
22.3.9.6. Key Developments
22.3.9.7. Strategy Overview
22.3.9.7.1. Marketing Strategy
22.3.9.7.2. Product Strategy
22.3.9.7.3. Channel Strategy
22.3.10. W. L. Gore & Associates Inc.
22.3.10.1. Overview
22.3.10.2. Product Portfolio
22.3.10.3. Sales Footprint
22.3.10.4. Key Financials
22.3.10.5. SWOT Analysis
22.3.10.6. Key Developments
22.3.10.7. Strategy Overview
22.3.10.7.1. Marketing Strategy
22.3.10.7.2. Product Strategy
22.3.10.7.3. Channel Strategy
23. Assumptions and Acronyms Used
24. Research Methodology